Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.0026 USD
Change Today 0.00 / 0.00%
Volume 8.1K
As of 8:10 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

redpoint bio corp (RPBC) Snapshot

Previous Close
Day High
Day Low
52 Week High
09/19/14 - $0.0072
52 Week Low
06/8/15 - $0.0015
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for REDPOINT BIO CORP (RPBC)

Related News

No related news articles were found.

redpoint bio corp (RPBC) Related Businessweek News

No Related Businessweek News Found

redpoint bio corp (RPBC) Details

Redpoint Bio Corporation, a development stage biotechnology company, focuses on the development of healthier foods and new approaches for the treatment of diabetes and obesity by understanding the biology of taste and its relationship to metabolism, satiety, and diabetes. It enters into a license and commercialization agreement with International Flavors and Fragrances Inc. for the development, manufacture, use, and commercialization of RP44, which is a component of the stevia plant that works as a sweetness enhancer amplifying the existing sugary sweetness in a food or beverage. The company is based in Philadelphia, Pennsylvania.

redpoint bio corp (RPBC) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

redpoint bio corp (RPBC) Key Developments

Redpoint Bio Corporation Replaces KPMG LLP with D'arelli Pruzansky, P.A as Independent Registered Public Accounting Firm

On August 1, 2014, the Audit Committee of the Board of Directors of Redpoint Bio Corporation dismissed KPMG as the Company's independent registered public accounting firm, effective immediately. KPMG's audit reports on the Company's financial statements for the two most recent fiscal years for which KPMG conducted an audit, which were for the years ended December 31, 2011 and 2010, and for the period from August 16, 1995 to December 31, 2011, did not contain any adverse opinion or disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope, or accounting principles. Following the approval to change accountants by the Audit Committee on August 1, 2014, the Company engaged D'Arelli Pruzansky, P.A. as its new independent registered public accounting firm.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RPBC:US $0.00 USD 0.00

RPBC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Ajinomoto Co Inc ¥2,610 JPY -62.00
GLG Life Tech Corp C$0.34 CAD 0.00
PureCircle Ltd 400.00 GBp 0.00
Symrise AG €53.62 EUR -0.013
Tate & Lyle PLC 542.00 GBp +4.00
View Industry Companies

Industry Analysis


Industry Average

Valuation RPBC Industry Range
Price/Earnings 32.7x
Price/Sales 0.4x
Price/Book NM Not Meaningful
Price/Cash Flow 32.7x
TEV/Sales 0.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REDPOINT BIO CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at